Comparison of the Hypoglycemic Effect of Acarbose Monotherapy in Patients With Type 2 Diabetes Mellitus Consuming an Eastern or Western Diet: A Systematic Meta-analysis
- 1 June 2013
- journal article
- research article
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 35 (6), 880-899
- https://doi.org/10.1016/j.clinthera.2013.03.020
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Effect of a Multifactorial Intervention on Mortality in Type 2 DiabetesThe New England Journal of Medicine, 2008
- Treating Postprandial Hyperglycemia Does Not Appear to Delay Progression of Early Type 2 DiabetesDiabetes Care, 2006
- Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised studyThe Lancet, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- The PROTECT study: final results of a large multicenter postmarketing study in patients with type 2 diabetesClinical Therapeutics, 1998
- U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study GroupDiabetes, 1995
- Efficacy of 24-Week Monotnerapy With Acarbose, Glibenclamide, or Placebo in NIDDM Patients: The Essen StudyDiabetes Care, 1994
- Therapeutic Potentials of Acarbose as First-Line Drug in NIDDM Insufficiently Treated With Diet AloneDiabetes Care, 1991
- Effectiveness of acarbose, an alpha-glucosidase inhibitor, in uncontrolled non-obese non-insulin dependent diabetesEuropean Journal of Clinical Pharmacology, 1988